By Chris Wack Renovaro Biosciences shares were up 7% to $4.34 after the company said it is buying GEDi Cube International, an AI medical technology company,.
BioMedNewsBreaks — Renovaro BioSciences Inc (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of Renovaro Biosciences Inc. (RENB) are climbing over 6% on Friday after announcing its definitive agreement to merge with GEDi Cube Intl Ltd., a medical technology company specializing in AI.
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.